OM Outset Medical Inc

USD 2.20 0.00 0
Icon

Outset Medical Inc (OM) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.20

0.00 (0.00)%

USD 0.10B

0.37M

USD 7.30(+231.82%)

N/A

Icon

OM

Outset Medical Inc (USD)
COMMON STOCK | NSD
USD 2.20
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.10B

N/A

USD 2.20

Outset Medical Inc (OM) Stock Forecast

Show ratings and price targets of :
USD 7.30
(+231.82%)

Based on the Outset Medical Inc stock forecast from 4 analysts, the average analyst target price for Outset Medical Inc is USD 7.30 over the next 12 months. Outset Medical Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Outset Medical Inc is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Outset Medical Inc’s stock price was USD 2.20. Outset Medical Inc’s stock price has changed by -0.90% over the past week, -41.95% over the past month and -88.26% over the last year.

No recent analyst target price found for Outset Medical Inc
No recent average analyst rating found for Outset Medical Inc

Company Overview Outset Medical Inc

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and s...Read More

3052 Orchard Drive, San Jose, CA, United States, 95134

480

December

USD

USA

Adjusted Closing Price for Outset Medical Inc (OM)

Loading...

Unadjusted Closing Price for Outset Medical Inc (OM)

Loading...

Share Trading Volume for Outset Medical Inc Shares

Loading...

Compare Performance of Outset Medical Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for OM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Outset Medical Inc (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DXCM
DexCom Inc -0.45 (-0.32%) USD51.34B 103.24 55.96

ETFs Containing OM

Symbol Name OM's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Outset Medical Inc (OM) Stock

Based on ratings from 4 analysts Outset Medical Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 2 buy, 1 sell and 2 hold ratings.

Unfortunately we do not have enough data on OM's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for OM is USD 7.30 over the next 12 months. The maximum analyst target price is USD 17 while the minimum anlayst target price is USD 3.

Unfortunately we do not have enough data on OM's stock to indicate if its overvalued.

The last closing price of OM's stock was USD 2.20.

The most recent market capitalization for OM is USD 0.10B.

Based on targets from 4 analysts, the average taret price for OM is projected at USD 7.30 over the next 12 months. This means that OM's stock price may go up by +231.82% over the next 12 months.

We can't find any ETFs which contains Outset Medical Inc's stock.

As per our most recent records Outset Medical Inc has 480 Employees.

Outset Medical Inc's registered address is 3052 Orchard Drive, San Jose, CA, United States, 95134. You can get more information about it from Outset Medical Inc's website at https://www.outsetmedical.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...